Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Glabellar Frown Lines”

44 trials

Showing 20 of 44 results

Testing effectiveness (Phase 2)Study completedNCT01485601
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin Type A to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 121
Post-approval studies (Phase 4)Study completedNCT01391312
What this trial is testing

Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines

Who this might be right for
Glabellar Frown Lines
Allergan 40
Large-scale testing (Phase 3)Study completedNCT05059587
What this trial is testing

Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 318
Large-scale testing (Phase 3)Study completedNCT06585696
What this trial is testing

Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)

Who this might be right for
Glabellar Frown Lines
Cutia Therapeutics（Wuxi）Co.,Ltd 554
Large-scale testing (Phase 3)Study completedNCT06946160
What this trial is testing

A Non-inferiority Clinical Trial to Compare Efficacy and Safety of Abobotulinumtoxin A (Espad Pharmed) Versus AbobotulinumtoxinA (Dysport®, Ipsen Co.) for Correction of Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar LinesGlabellar Frown Lines
Espad Pharmed 146
Very early researchUnknownNCT05083286
What this trial is testing

Duration of Botox Using OLD Versus COLD for Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)UnknownNCT05623410
What this trial is testing

Study to Compare the Efficacy and Safety of ATGC-110 (Botulinum Toxin) With Xeomin® for the Treatment of Moderate to Severe Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
ATGC Co., Ltd. 300
Post-approval studies (Phase 4)Study completedNCT01814670
What this trial is testing

Treatment With Botulinum Toxin Type A (BOTOX®) in Chinese Patients With Moderate to Severe Frown Lines

Who this might be right for
Glabellar Rhytides
Allergan 185
Testing effectiveness (Phase 2)Study completedNCT04143815
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medy-Tox 200
Testing effectiveness (Phase 2)Study completedNCT02184988
What this trial is testing

Safety Study of DWP-450 (Botulinum Purified Neurotoxin, Type A) Injection to Treat Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Evolus, Inc. 352
Very early researchUnknownNCT05305768
What this trial is testing

Xeomin Treatment of Glabellar Lines Using OLD Versus COLD

Who this might be right for
Glabellar Frown Lines
Clinical Testing of Beverly Hills 40
Large-scale testing (Phase 3)Study completedNCT00770029
What this trial is testing

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Glabellar Frown Lines No. 2

Who this might be right for
Moderate to Severe Glabellar Frown Lines
Merz Pharmaceuticals GmbH 276
Large-scale testing (Phase 3)Study completedNCT03004248
What this trial is testing

Safety of Single and Repeat Treatments of DaxibotulinumtoxinA for Injection for Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Revance Therapeutics, Inc. 2,691
Post-approval studies (Phase 4)UnknownNCT04281745
What this trial is testing

Long-term Open-label Treatment of Moderate to Severe Glabellar Lines With CORETOX®

Who this might be right for
Glabellar Frown Lines
Medy-Tox 200
Large-scale testing (Phase 3)Study completedNCT04247074
What this trial is testing

Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

Who this might be right for
Glabellar Frown Lines (GL)Lateral Canthal Lines (LCL)
Galderma R&D 413
Testing effectiveness (Phase 2)Study completedNCT01333397
What this trial is testing

Safety and Efficacy Study of Dysport RU and Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Ipsen 176
Large-scale testing (Phase 3)Study completedNCT05364580
What this trial is testing

The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Protox Inc. 269
Testing effectiveness (Phase 2)Study completedNCT02236312
What this trial is testing

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 359
Large-scale testing (Phase 3)Study completedNCT05321979
What this trial is testing

Long-term Extension Study to Evaluate MBA-P01 in Subjects With Moderate to Severe Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Medytox Korea 253
Testing effectiveness (Phase 2)Study completedNCT03736928
What this trial is testing

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Who this might be right for
Glabellar Frown Lines
Galderma R&D 401
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation